Prescription denials for GLP-1 receptor agonists across commercial, Medicare, and Medicaid coverage, 2018-2024

Miaoqing Jia, Joseph F Levy, Emma E McGinty, Sri Lekha Tummalapalli, Yongkang Zhang

Open source

DOI
10.1093/haschl/qxag284
Published
2026-10
Container
Health Affairs Scholar
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/haschl/qxag284,
  title = {Prescription denials for GLP-1 receptor agonists across commercial, Medicare, and Medicaid coverage, 2018-2024},
  author = {Miaoqing Jia and Joseph F Levy and Emma E McGinty and Sri Lekha Tummalapalli and Yongkang Zhang},
  year = {2026},
  journal = {Health Affairs Scholar},
  doi = {10.1093/haschl/qxag284},
  url = {https://doi.org/10.1093/haschl/qxag284}
}

RIS

TY  - JOUR
TI  - Prescription denials for GLP-1 receptor agonists across commercial, Medicare, and Medicaid coverage, 2018-2024
AU  - Miaoqing Jia
AU  - Joseph F Levy
AU  - Emma E McGinty
AU  - Sri Lekha Tummalapalli
AU  - Yongkang Zhang
PY  - 2026
JO  - Health Affairs Scholar
DO  - 10.1093/haschl/qxag284
UR  - https://doi.org/10.1093/haschl/qxag284
ER  - 

APA

Jia, M., Levy, J. F., McGinty, E. E., Tummalapalli, S. L., & Zhang, Y. (2026). Prescription denials for GLP-1 receptor agonists across commercial, Medicare, and Medicaid coverage, 2018-2024. Health Affairs Scholar. https://doi.org/10.1093/haschl/qxag284

Source records